A pharmaceutical company has revoked drugs for blood pressure after detecting traces of a cancer-causing chemical. The Food and Drug Administration has announced that Torrent Pharmaceuticals Limited is voluntarily recalling two batches of Losartan potassium tablets.
The FDA said the products contain trace amounts of N-nitrosodiethylamine (NDEA), which is a "naturally occurring substance in certain foods, potable water, air pollution and industrial processes, and has been classified as a probable human carcinogen."
Losartan is used to treat high blood pressure (hypertension). According to the Mayo Clinic, hypertension can "damage the blood vessels of the brain, heart and kidneys, resulting in stroke, heart failure, or kidney failure."
The FDA said that patients taking Losartan should continue to take their medications, as discontinuing treatment immediately can be harmful. The FDA advised patients to contact their pharmacist or doctor about possible alternative treatments.
Visit the FDA website to see more information about the recovered medicine.
© 2018 by 10TV.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.